BioStem Technologies (OTCQB: BSEM)

As the tournament starts the round of 64 today, we're joining in with our own BioStem Bracket Challenge! Who are you picking to go all the way? Good luck to all the teams.

🍀 Happy St. Patrick’s Day from BioStem Technologies! 🍀 At BioStem Technologies, we believe breakthroughs aren’t found at the end of a rainbow — they’re built through research, dedication, and a commitment to advancing wound care. $BSEM #Biostem

BioStem will release its Fourth Qtr and Full Year 2025 financial results on 3-24-26 Conference Call & Webcast Information: Conference ID: 9695874 North America Toll-Free: (800) 715-9871 Webcast Link: hubs.ly/Q046BWWb0 For more info, click here: hubs.ly/Q046C0lm0 $BSEM

We’re proud to share that our Lead Research Scientist, Toni-Ann Martorano, presented this past Friday at the CAMPs 2026 Conference in West Palm Beach The science matters. The patients matter. And the results speak for themselves. $BSEM #BioREtain #DFU #ClinicalResearch

We wrapped up an incredible week at the Acellular and Matrix-like Products (CAMPs) Wound Care Summit. Thank you to everyone who stopped by to learn more about our allograft solutions and the science driving better healing. $BSEM #CAMPs2026

As our team continues to grow and expand, we remain deeply committed to preserving the family culture that has made BioStem such an amazing place to work. Growth is exciting — but culture is everything. $BSEM #employeeappreciation #companyculture

We’re excited to share that Toni-Ann Martorano, Research Scientist at BioStem Technologies, will be presenting during the Rapid Fire Session at the 3rd Annual CAMPs Wound Care Summit in West Palm Beach, from 5:50–5:55 PM (followed by Q&A) #CAMPs2026 #WoundCare $BSEM

We now have 9 CTBS-certified professionals, in our Lab Operations and Quality team, with more team members preparing to pass the certification exam this year. Their dedication ensures that every allograft we produce meets uncompromising standards of safety and quality. $BSEM

We’re excited to share that Toni-Ann Martorano, Research Scientist at BioStem Technologies, will be presenting during the Rapid Fire Session at the 3rd Annual CAMPs Wound Care Summit in West Palm Beach.Rapid Fire Session: 5:10–6:00 PM. #CAMPs2026 #WoundCare #DiabeticFootUlcers

Thank you to everyone who took the time to learn more about BioStem Technologies and how we’re elevating wound care innovation. If we haven't met yet, please stop by today to say hello to the team. #ACFAS #BioStem #WoundCareInnovation #InRelentlessPursuitOfHealing

BioStem Technologies will be attending the ACFAS Scientific Conference 2026 in Las Vegas from February 24–26. Stop by Booth #2929 to connect with our team and learn more about our amniotic tissue allografts—powered by the proprietary BioREtain® process. #ACFAS2026 $BSEM

We’re still buzzing after last week’s New Year, New Stem kickoff meeting. Bringing the BioTissue Surgical team together with the entire BioStem organization wasn’t just a meeting — it was a milestone. New faces. New energy. New opportunities. $BSEM #BioStem #TeamGrowth

On Thursday evening, we officially welcomed the BioTissue Surgical & Wound Care sales team to BioStem Technologies. We are proud to bring together two high-performing teams united by a commitment to advancing wound care and delivering better outcomes for patients. $BSEM #NewStem

If you're treating veterans with complex wounds, we want to work with you. Give us your toughest wounds and explore how American Amnion fits into advanced wound care protocols. Learn more at: hubs.ly/Q03_LdBM0 #AmericanAmnion $BSEM #woundcare #veterans

When wounds stall, recur, or resist standard care, it’s time to think differently. American Amnion™ was developed with these realities in mind. Find our more with our new blog - click here: hubs.ly/Q042FXD50 #WoundCare $BSEM #AmericanAmnion #VAHealthcare #advancedwoundcare

BioStem Technologies will be attending the ACFAS Scientific Conference 2026 in Las Vegas from February 24–26. Stop by Booth #2929 to connect with our team and learn more about our amniotic tissue allografts—powered by the proprietary BioREtain® process. #ACFAS2026 $BSEM

When traditional treatments reach their limits, innovation has to step in. We focus on advancing wound care for complex cases—especially for veterans who deserve solutions that meet the full scope of their needs. Learn more: hubs.ly/Q0425SKC0 #BSEM #veterans #woundcare

Chronic wounds—such as DFUs, VLUs, pressure ulcers, and non-healing surgical wounds—are often stalled in a prolonged inflammatory state. Leaving them uncovered can further disrupt the wound environment. hubs.ly/Q03_P5wj0 #WoundCareWednesday $BSEM

BioStem Technologies welcomes recent remarks from FDA Commissioner Dr. Martin Makary, who described the agency’s openness to Bayesian statistical approaches as a “leap forward” for clinical science. hubs.ly/Q041Gvjg0 $BSEM #BayesianStatistics #WoundCare #FDA #BioREtain

BioStem Technologies will be attending the ACFAS Scientific Conference 2026 in Las Vegas from February 24–26. Stop by Booth #2929 to connect with our team and learn more about our amniotic tissue allografts—powered by the proprietary BioREtain® process. #ACFAS2026 $BSEM